Results 181 to 190 of about 300,238 (255)

Topical Heparin in Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. [PDF]

J Burn Care Res
Nassar M, Mohamed MI, Shahid M, Taha R, Alweshah RW, Yousef MR, Eltagouri Y, Gustavo DG.   +7 more
europepmc   +1 more source

No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects

International Journal of Cancer, EarlyView.
What's New? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander, Alessandra I. G. Buma, Jenneke Leentjens, Paddy K. C. Janssen, Michel M. van den Heuvel, David M. Burger, Berber Piet, Rob ter Heine   +7 more
wiley   +1 more source

Triple Therapy: A Safe, Cost-Effective Regimen of Heparin, Aspirin and Clopidogrel for Managing Intracranial Vessel Occlusions in Patients With Acute Ischemic Stroke Who Are Ineligible for Intravenous Thrombolytics and Endovascular Thrombectomy. [PDF]

Stroke Vasc Interv Neurol
Chaudhari A, Almajali M, Khan N, Bhattarai A, Ramirez-Abreu D, Al-Ghetaa JK, Ashouri Y, Almajali F, Limaye K, Jones A, Yaghi S, Nguyen T, Lin E, Zaidat OO.   +13 more
europepmc   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar, Ahmad Badeghiesh, Haitham Baghlaf, Michael H. Dahan   +3 more
wiley   +1 more source

Co-delivery of synaptogenic and angiogenic nanoparticles in MAP scaffolds enhances post-stroke synapse formation.

J Mater Chem B
Phan NV, Thomas JL, Pasinsky A, Meadows Z, Li TT, Adams A, Zhu Y, Edgcomb A, Shi Y, Lyu S, Dunn TW, Segura T.   +11 more
europepmc   +1 more source

A Diagnostic Challenge: Post-Transfusion Purpura Unmasked After Multiple Transfusions. [PDF]

Clin Case Rep
Thomas J, Gopalan P, Wildes TM.
europepmc   +1 more source

A new, rapid, chemiluminescence enzyme assay for the detection of heparin-induced thrombocytopenia: a comparison between functional and immune heparin-induced thrombocytopenia assays. [PDF]

Res Pract Thromb Haemost
Bowyer A, Kohama K, Patel I, Kobayashi K, Hasegawa R, Mukaida A, Greinacher A, Kitchen S.   +7 more
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

Isorhamnetin Alleviates Renal Fibrosis Induced by Renal Tubular Epithelial Cell Senescence Via Inhibition of the IL‐6/IL‐6R Signaling Pathway

iMetaMed, EarlyView.
IL‐6 from RTECs upregulates TGF‐β in macrophages, promoting fibroblast transdifferentiation. Isorhamnetin inhibits this effect. ABSTRACT Chronic kidney disease (CKD) is a major global health issue. Kidney fibrosis is a key mechanism leading to end‐stage renal disease.
Weifei Liang, Xiangqiu Chen, Tao Wu, Xichun Zheng, Shaohua Zeng, Qingchun Zhou, Wen Ma, Hao Lin, Donglin Sun   +8 more
wiley   +1 more source